103 related articles for article (PubMed ID: 18614849)
1. Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma.
Abe H; Kamai T; Tsujii T; Nakamura F; Mashidori T; Mizuno T; Tanaka M; Tatsumiya K; Furuya N; Masuda A; Yamanishi T; Yoshida K
Biomed Res; 2008 Jun; 29(3):155-61. PubMed ID: 18614849
[TBL] [Abstract][Full Text] [Related]
2. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
3. [Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma].
Bu Q; Tang HM; Tan J; Hu X; Wang DW
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):202-6. PubMed ID: 21575520
[TBL] [Abstract][Full Text] [Related]
4. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
Horiuchi A; Imai T; Wang C; Ohira S; Feng Y; Nikaido T; Konishi I
Lab Invest; 2003 Jun; 83(6):861-70. PubMed ID: 12808121
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
7. Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
Masuda A; Kamai T; Abe H; Arai K; Yoshida K
Biomed Res; 2009 Jun; 30(3):171-6. PubMed ID: 19574718
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
9. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.
Suwa H; Ohshio G; Imamura T; Watanabe G; Arii S; Imamura M; Narumiya S; Hiai H; Fukumoto M
Br J Cancer; 1998; 77(1):147-52. PubMed ID: 9459160
[TBL] [Abstract][Full Text] [Related]
11. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
12. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
15. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.
Wang HB; Liu XP; Liang J; Yang K; Sui AH; Liu YJ
Clin Chem Lab Med; 2009; 47(7):811-7. PubMed ID: 19499974
[TBL] [Abstract][Full Text] [Related]
16. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
[TBL] [Abstract][Full Text] [Related]
17. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
18. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
Wu K; Xu L; Zhang L; Lin Z; Hou J
Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
[TBL] [Abstract][Full Text] [Related]
19. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour.
Kamai T; Arai K; Tsujii T; Honda M; Yoshida K
BJU Int; 2001 Feb; 87(3):227-31. PubMed ID: 11167647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
